loadpatents
name:-0.063332080841064
name:-0.053695917129517
name:-0.00055718421936035
Aventis Pasteur, Ltd. Patent Filings

Aventis Pasteur, Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aventis Pasteur, Ltd..The latest application filed is for "tumor antigens bfa4 and bcy1 for prevention and / or treatment of cancer".

Company Profile
0.34.34
  • Aventis Pasteur, Ltd. -
  • AVENTIS PASTEUR LIMITED - TORONTO CA
  • Aventis Pasteur Ltd - Toronto CA
  • Aventis Pasteur Ltd. - Toronto CA
  • Aventis Pasteur, Ltd. - 1755 W. Steeles Ave. Toronto CA
  • Aventis Pasteur Limited - 1755 Steels Avenue West Connaught Campus Toronto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tumor Antigens Bfa4 And Bcy1 For Prevention And / Or Treatment Of Cancer
App 20110117640 - Berinstein; Neil ;   et al.
2011-05-19
Chlamydia Antigens And Protein Vaccine
App 20090155350 - MURDIN; ANDREW D. ;   et al.
2009-06-18
Chlamydia Polypeptides And Corresponding Dna Fragments And Uses Thereof
App 20090142376 - Murdin; Andrew D. ;   et al.
2009-06-04
Chlamydia OMP antigen
App 20080112965 - Murdin; Andrew D. ;   et al.
2008-05-15
Chlamydia flagellar protein antigen
App 20080095793 - Murdin; Andrew D. ;   et al.
2008-04-24
Chlamydia antigens and corresponding DNA fragments and uses thereof
Grant 7,335,370 - Murdin , et al. February 26, 2
2008-02-26
Transferrin receptor genes of moraxella
Grant 7,241,449 - Myers , et al. July 10, 2
2007-07-10
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
App 20070031852 - Doucette-Stamm; Lynn ;   et al.
2007-02-08
Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
App 20070009906 - Doucette-Stamm; Lynn ;   et al.
2007-01-11
Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
App 20070009904 - Doucette-Stamm; Lynn ;   et al.
2007-01-11
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
App 20070009901 - Doucette-Stamm; Lynn ;   et al.
2007-01-11
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
App 20070009903 - Doucette-Stamm; Lynn ;   et al.
2007-01-11
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
App 20070009902 - Doucette-Stamm; Lynn ;   et al.
2007-01-11
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
App 20070009900 - Doucette-Stamm; Lynn ;   et al.
2007-01-11
Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
App 20070009905 - Doucette-Stamm; Lynn ;   et al.
2007-01-11
Multi-antigen vectors of melanoma
App 20060127360 - Berinstein; Neil ;   et al.
2006-06-15
Co-expression of recombination proteins
Grant 7,015,033 - Loosmore , et al. March 21, 2
2006-03-21
Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles
Grant 7,008,784 - Haynes , et al. March 7, 2
2006-03-07
Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
Grant 6,974,581 - Loosmore , et al. December 13, 2
2005-12-13
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20050220805 - Murdin, Andrew D. ;   et al.
2005-10-06
Chlamydia antigens and vaccine uses of the protein
App 20050202048 - Murdin, Andrew D. ;   et al.
2005-09-15
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20050186266 - Murdin, Andrew D. ;   et al.
2005-08-25
Tumor antigen BFA5 for prevention and / or treatment of cancer
App 20050112099 - Berinstein, Neil ;   et al.
2005-05-26
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20050069942 - Murdin, Andrew D. ;   et al.
2005-03-31
Chlamydia antigens and corresponding DNA fragments and uses thereof
Grant 6,872,814 - Murdin , et al. March 29, 2
2005-03-29
Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor
Grant 6,855,537 - Papadopoulu , et al. February 15, 2
2005-02-15
Protective recombinant Haemophilus influenzae high molecular weight proteins
Grant 6,849,447 - Loosmore , et al. February 1, 2
2005-02-01
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20050002944 - Murdin, Andrew D. ;   et al.
2005-01-06
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20050002960 - Murdin, Andrew D. ;   et al.
2005-01-06
Enhancement of the immune response using CD36-binding domain
App 20040241652 - Cox, William I. ;   et al.
2004-12-02
Immunogenic compositions for protection against chlamydial infection
Grant 6,811,783 - Murdin , et al. November 2, 2
2004-11-02
Chlamydia antigens and corresponding DNA fragments and uses thereof
Grant 6,808,713 - Murdin , et al. October 26, 2
2004-10-26
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
App 20040197912 - Berinstein, Neil ;   et al.
2004-10-07
Adjuvant compositions containing more than one adjuvant
Grant 6,764,682 - Kandil , et al. July 20, 2
2004-07-20
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20040086525 - Murdin, Andrew D. ;   et al.
2004-05-06
Nucleic acid molecules encoding POMP91A protein of Chlamydia
Grant 6,693,087 - Murdin , et al. February 17, 2
2004-02-17
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
Grant 6,686,339 - Murdin , et al. February 3, 2
2004-02-03
Two-step immunization procedure against Chlamydia infection
Grant 6,676,949 - Brunham , et al. January 13, 2
2004-01-13
Nucleic acid respiratory syncytial virus vaccines
Grant 6,677,127 - Li , et al. January 13, 2
2004-01-13
Targeted immunogens
App 20040002455 - Uger, Robert Adam ;   et al.
2004-01-01
Chlamydia antigens and corresponding DNA fragments and uses thereof
Grant 6,660,275 - Murdin , et al. December 9, 2
2003-12-09
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20030224004 - Murdin, Andrew D. ;   et al.
2003-12-04
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20030225017 - Murdin, Andrew D. ;   et al.
2003-12-04
Multi oligosaccharide glycoconjugate bacterial meningitis vaccines
Grant 6,656,472 - Chong , et al. December 2, 2
2003-12-02
Chlamydia antigens and corresponding DNA fragments and uses thereof
Grant 6,649,370 - Murdin , et al. November 18, 2
2003-11-18
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20030206921 - Murdin, Andrew D. ;   et al.
2003-11-06
Chlamydia antigens and corresponding DNA fragments and uses thereof
Grant 6,642,025 - Murdin , et al. November 4, 2
2003-11-04
Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
Grant 6,635,746 - Murdin , et al. October 21, 2
2003-10-21
DNA immunization against chlamydia infection
Grant 6,632,663 - Brunham October 14, 2
2003-10-14
Biodegradable targetable microparticle delivery system
Grant 6,623,764 - Sokoll , et al. September 23, 2
2003-09-23
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20030161833 - Murdin, Andrew D. ;   et al.
2003-08-28
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20030157123 - Murdin, Andrew D. ;   et al.
2003-08-21
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20030157124 - Murdin, Andrew D. ;   et al.
2003-08-21
Immunogenic targets for melanoma
App 20030113919 - Emtage, Peter ;   et al.
2003-06-19
Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region
Grant 6,544,527 - Rovinski , et al. April 8, 2
2003-04-08
Alphavirus vectors for paramyxovirus vaccines
Grant 6,475,780 - Parrington , et al. November 5, 2
2002-11-05
High molecular weight major outer membrane protein of moraxella
Grant 6,440,424 - Sasaki , et al. August 27, 2
2002-08-27
High molecular weight major outer membrane protein of moraxella
Grant 6,440,425 - Sasaki , et al. August 27, 2
2002-08-27
Transferrin receptor of moraxella
Grant 6,437,096 - Myers , et al. August 20, 2
2002-08-20
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20020081682 - Murdin, Andrew D. ;   et al.
2002-06-27
Chlamydia antigens and corresponding DNA fragments and uses thereof
App 20020037293 - Murdin, Andrew D. ;   et al.
2002-03-28
Transferrin receptor genes
Grant 6,361,779 - Loosmore , et al. March 26, 2
2002-03-26
Haemophilus transferrin receptor genes
Grant 6,358,727 - Loosmore , et al. March 19, 2
2002-03-19
Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzae
Grant 6,342,232 - Loosmore , et al. January 29, 2
2002-01-29
Subunit respiratory syncytial virus vaccine preparation
Grant 6,309,649 - Cates , et al. October 30, 2
2001-10-30
Chimeric antibodies for delivery of antigens to selected cells of the immune system
Grant 6,291,208 - Anand , et al. September 18, 2
2001-09-18
Transferrin receptor protein of Moraxella
Grant 6,290,970 - Yang , et al. September 18, 2
2001-09-18
Biodegradable targetable microparticle delivery system
Grant 6,287,604 - Sokoll , et al. September 11, 2
2001-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed